A randomised trial to compare dolutegravir+darunavir/r versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first line therapy [ 2016 - 2019 ]

Research Grant

[Cite as]

Researchers: Prof David Cooper (Principal investigator) ,  Dr Marcelo Losso Dr Nagalingeswaran Kumarasamy Dr Rebekah Puls Prof Janaki Amin
View all 6 related researchers

Brief description Public sector programs for provision of antiretroviral drugs in developing countries need regimens of therapy that are safe, effective and simple to administer. The evidence base to support first line therapy is strong. This contrasts with a relative paucity of evidence for second regimens of therapy once first line effectiveness has been lost. This trial will address that evidential deficit and support evidence-based recommendations for global health.

Funding Amount $AUD 2,396,002.79

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]